Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Well Differentiated Pancreatic Endocrine Tumor”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02230176
What this trial is testing

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Who this might be right for
Pancreatic Neuroendocrine Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 84
Not applicableStudy completedNCT03616431
What this trial is testing

Pancreatic Cancer Dietary Assessment Study

Who this might be right for
Pancreatic NeoplasmPancreas AdenocarcinomaWell-Differentiated Neuroendocrine Carcinoma+1 more
The Christie NHS Foundation Trust 112
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Testing effectiveness (Phase 2)Study completedNCT00781911
What this trial is testing

Cixutumumab (IMC-A12) in Islet Cell Cancer

Who this might be right for
CarcinomaNeuroendocrine Tumors
Eli Lilly and Company 43
Post-approval studies (Phase 4)Study completedNCT01525550
What this trial is testing

The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Who this might be right for
Well-differentiated Pancreatic Neuroendocrine Tumor
Pfizer 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784
What this trial is testing

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more
University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT02806648
What this trial is testing

A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)

Who this might be right for
Pancreatic Neuroendocrine Cancer
Grupo Espanol de Tumores Neuroendocrinos 21
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)UnknownNCT02294006
What this trial is testing

Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs

Who this might be right for
Well Differentiated Pancreatic Endocrine Tumor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26
Testing effectiveness (Phase 2)WithdrawnNCT02108782
What this trial is testing

Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+3 more
Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Active Not RecruitingNCT03351296
What this trial is testing

Two Chemotherapy Regimens Plus or Minus Bevacizumab

Who this might be right for
Pancreatic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 140
Early research (Phase 1)Looking for participantsNCT07165132
What this trial is testing

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Who this might be right for
GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+6 more
RayzeBio, Inc. 104
Testing effectiveness (Phase 2)Study completedNCT02713763
What this trial is testing

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib

Who this might be right for
Pancreatic Neuroendocrine Tumour Metastatic
Grupo Espanol de Tumores Neuroendocrinos 11
Large-scale testing (Phase 3)Ended earlyNCT00428597
What this trial is testing

Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Who this might be right for
Carcinoma, Islet CellCarcinoma, Pancreas
Pfizer 171
Testing effectiveness (Phase 2)Looking for participantsNCT05997056
What this trial is testing

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Who this might be right for
Neuroendocrine TumorsNETPancreatic Neuroendocrine Tumor+2 more
Aadi Bioscience, Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT01648465
What this trial is testing

Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

Who this might be right for
Gastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine Tumors+1 more
Hellenic Cooperative Oncology Group 25
Large-scale testing (Phase 3)Looking for participantsNCT05477576
What this trial is testing

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Who this might be right for
GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+4 more
RayzeBio, Inc. 338
Post-approval studies (Phase 4)Looking for participantsNCT06016855
What this trial is testing

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Digestive System Neuroendocrine Tumor G1Digestive System Neuroendocrine Tumor G2Metastatic Digestive System Neuroendocrine Neoplasm+3 more
Vanderbilt-Ingram Cancer Center 6
Load More Results